Coeur Mining's Q4 Strength Belies Persistent Execution and Valuation Risks

What happened

Coeur Mining reported robust Q4 2025 results, showing increased gold and silver production from the Rochester expansion and Las Chispas mine, alongside improved cash flow and reduced debt. This performance has fueled a 340% stock surge over the past year, positioning CDE as a momentum play in the precious metals sector. However, SEC filings indicate that Rochester's expansion remains execution-fragile, with past delays affecting incentive outcomes and limiting unit-cost leverage. Additionally, Las Chispas's cost metrics are distorted by purchase price allocation impacts, and the pending New Gold acquisition hinges on Investment Canada Act approval, which is not yet secured. While the Q4 report appears positive, it masks underlying operational and regulatory risks that could derail the high expectations embedded in the current valuation.

Implication

The strong Q4 results validate near-term operational improvements but do not eliminate the structural risks highlighted in filings, such as Rochester's fragility and Las Chispas integration noise. With valuation multiples at elevated levels (EV/EBITDA 38.0x), any delay in Rochester's performance or New Gold approval could trigger significant downside, as the market has priced in perfection. Investors should closely monitor the Investment Canada Act decision by May 2026 and Las Chispas cost normalization for signs of progress or failure, which are critical to the investment thesis. The clustered insider selling in 2025, including large sales by executives, adds to concerns about internal confidence and suggests the stock may be overextended. A prudent approach is to wait for either a lower entry price or concrete de-risking events, such as regulatory approval and sustained guidance, before increasing exposure.

Thesis delta

The Q4 report confirms operational momentum but does not alter the fundamental thesis that CDE is overvalued relative to execution risks, maintaining the 'WAIT' rating. Investors should still await Investment Canada Act approval and sustained Rochester performance before considering an upgrade, as the news reinforces rather than resolves key uncertainties.